Biologicals and Biomaterials for Corneal Regeneration and Vision Restoration in Limbal Stem Cell Deficiency

• Published in: Advanced materials (Weinheim) Vol. 36; no. 42; pp. e2401763 - n/a
• Main Author: Di Girolamo, Nick
• Format: Journal Article
• Language: English
• Published: Germany Wiley Subscription Services, Inc 01.10.2024
• Subjects: Animals; Biocompatibility; Biocompatible Materials - chemistry; Biocompatible Materials - pharmacology; Biological properties; biomaterials; Biomechanical engineering; Biomechanics; Biomedical engineering; Biomedical materials; Contact lenses; cornea; Cornea - cytology; Cornea - metabolism; Corneal Diseases - drug therapy; Corneal Diseases - therapy; Fibrin; Humans; Limbal Stem Cell Deficiency; limbal stem cells; Limbus Corneae - cytology; Micropatterning; Regeneration - drug effects; Scaffolds; Self-assembly; Stem Cell Transplantation; Stem cells; Stem Cells - cytology; Stem Cells - metabolism; Tissue Engineering - methods; Tissue Scaffolds - chemistry; scaffolds; biomaterials; limbal stem cell deficiency; cornea; limbal stem cells
• ISSN: 0935-9648; 1521-4095; 1521-4095
• DOI: 10.1002/adma.202401763

The mammalian cornea is decorated with stem cells bestowed with the life‐long task of renewing the epithelium, provided they remain healthy, functional, and in sufficient numbers. If not, a debilitating disease known as limbal stem cell deficiency (LSCD) can develop causing blindness. Decades after the first stem cell (SC) therapy is devised to treat this condition, patients continue to suffer unacceptable failures. During this time, improvements to therapeutics have included identifying better markers to isolate robust SC populations and nurturing them on crudely modified biological or biomaterial scaffolds including human amniotic membrane, fibrin, and contact lenses, prior to their delivery. Researchers are now gathering information about the biomolecular and biomechanical properties of the corneal SC niche to decipher what biological and/or synthetic materials can be incorporated into these carriers. Advances in biomedical engineering including electrospinning and 3D bioprinting with surface functionalization and micropatterning, and self‐assembly models, have generated a wealth of biocompatible, biodegradable, integrating scaffolds to choose from, some of which are being tested for their SC delivery capacity in the hope of improving clinical outcomes for patients with LSCD. Scaffolds with stem cells to rehabilitate the ocular surface in patients with limbal stem cell deficiency. Native and synthetic scaffolds, as carriers of stem cells, are being developed and transplanted to treat individuals with limbal stem cell deficiency (LSCD). Successful outcomes include restoration of tissue architecture and improvements in ocular health and vision without causing complications.